Yüklüyor......
Designing clinical trials to test disease-modifying agents—application to the treatment trials of Alzheimer's disease
BACKGROUND: Therapeutic trials of disease-modifying agents on Alzheimer’s disease (AD) require novel designs and analyses involving switch of treatments for at least a portion of subjects enrolled. Randomized start and randomized withdrawal designs are two examples of such designs. Crucial design pa...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3146242/ https://ncbi.nlm.nih.gov/pubmed/21335587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774510392391 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|